Companies: 11,345     total market cap: A$220.203 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Lexicon Pharmaceuticals
LXRX
#6759
Rank
A$1.12 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
A$2.52
Share price
0.29%
Change (1 day)
6.94%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Lexicon Pharmaceuticals (LXRX) - Cash on Hand

Cash on Hand as of June 2026 : A$0.27 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company has A$0.27 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lexicon Pharmaceuticals - Cash on Hand chart (from 2000 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31A$0.14 B-62.45%
2024-12-31A$0.38 B53.3%
2023-12-31A$0.24 B22.75%
2022-12-31A$0.20 B69.93%
2021-12-31A$0.11 B-39.58%
2020-12-31A$0.19 B-48.96%
2019-12-31A$0.38 B70.78%
2018-12-31A$0.22 B-42.93%
2017-12-31A$0.39 B-17.19%
2016-12-31A$0.48 B-32.83%
2015-12-31A$0.71 B72.6%
2014-12-31A$0.41 B186.42%
2013-12-31A$0.14 B-32.6%
2012-12-31A$0.21 B-21.82%
2011-12-31A$0.27 B32.19%
2010-12-31A$0.20 B14.88%
2009-12-31A$0.18 B23.78%
2008-12-31A$0.14 B-50.62%
2007-12-31A$0.29 B191.66%
2006-12-31A$0.10 B-25.52%
2005-12-31A$0.13 B20.42%
2004-12-31A$0.11 B-19.16%
2003-12-31A$0.13 B-15.76%
2002-12-31A$0.16 B-43.38%
2001-12-31A$0.29 B-19.06%
2000-12-31A$0.36 B2501.37%
1999-12-31A$13.93 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Thermo Fisher Scientific
TMO
A$5.83 B 2,032.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.65 B 505.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$11.47 B 4,094.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A$0.41 B 53.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$1.96 B 619.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$0.22 B-18.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A$0.24 B-9.52%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$1.25 B 358.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$7.21 M-97.36%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com